Literature DB >> 9547272

DNA binding properties of a chemically synthesized DNA binding domain of hRFX1.

F Cornille1, P Emery, W Schüler, C Lenoir, B Mach, B P Roques, W Reith.   

Abstract

The RFX DNA binding domain (DBD) is a novel highly conserved motif belonging to a large number of dimeric DNA binding proteins which have diverse regulatory functions in eukaryotic organisms, ranging from yeasts to human. To characterize this novel motif, solid phase synthesis of a 76mer polypeptide corresponding to the DBD of human hRFX1 (hRFX1/DBD), a prototypical member of the RFX family, has been optimized to yield large quantities (approximately 90 mg) of pure compound. Preliminary two-dimensional1H NMR experiments suggested the presence of helical regions in this sequence in agreement with previously reported secondary structure predictions. In gel mobility shift assays, this synthetic peptide was shown to bind in a cooperative manner the 23mer duplex oligodeoxynucleotide corresponding to the binding site of hRFX1, with a 2:1 stoichoimetry due to an inverse repeat present in the 23mer. The stoichiometry of this complex was reduced to 1:1 by decreasing the length of the DNA sequence to a 13mer oligonucleotide containing a single half-site. Surface plasmon resonance measurements were achieved using this 5'-biotylinated 13mer oligonucleotide immobilized on an avidin-coated sensor chip. Using this method an association constant (K a = 4 x 10(5)/M/s), a dissociation constant (K d = 6 x 10(-2)/s) and an equilibrium dissociation constant (K D = 153 nM) were determined for binding of hRFX1/DBD to the double-stranded 13mer oligonucleotide. In the presence of hRFX1/DBD the melting temperature of the 13mer DNA was increased by 16 degreesC, illustrating stabilization of the double-stranded conformation induced by the peptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547272      PMCID: PMC147513          DOI: 10.1093/nar/26.9.2143

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  N,O-bisFmoc derivatives of N-(2-hydroxy-4-methoxybenzyl)-amino acids: useful intermediates in peptide synthesis.

Authors:  T Johnson; M Quibell; R C Sheppard
Journal:  J Pept Sci       Date:  1995 Jan-Feb       Impact factor: 1.905

Review 2.  Regulation of MHC class II genes: lessons from a disease.

Authors:  B Mach; V Steimle; E Martinez-Soria; W Reith
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.

Authors:  I Kern; V Steimle; C A Siegrist; B Mach
Journal:  Int Immunol       Date:  1995-08       Impact factor: 4.823

4.  A revised set of potentials for beta-turn formation in proteins.

Authors:  E G Hutchinson; J M Thornton
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

5.  A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity.

Authors:  P Emery; M Strubin; K Hofmann; P Bucher; B Mach; W Reith
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins.

Authors:  W Reith; C Ucla; E Barras; A Gaud; B Durand; C Herrero-Sanchez; M Kobr; B Mach
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

7.  Binding of the HIV-1 nucleocapsid protein to the primer tRNA(3Lys), in vitro, is essentially not specific.

Authors:  Y Mély; H de Rocquigny; M Sorinas-Jimeno; G Keith; B P Roques; R Marquet; D Gérard
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

8.  RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom.

Authors:  P Emery; B Durand; B Mach; W Reith
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

9.  The sak1+ gene of Schizosaccharomyces pombe encodes an RFX family DNA-binding protein that positively regulates cyclic AMP-dependent protein kinase-mediated exit from the mitotic cell cycle.

Authors:  S Y Wu; M McLeod
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Authors:  V Steimle; B Durand; E Barras; M Zufferey; M R Hadam; B Mach; W Reith
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

View more
  5 in total

1.  The staphylococcal QacR multidrug regulator binds a correctly spaced operator as a pair of dimers.

Authors:  S Grkovic; M H Brown; M A Schumacher; R G Brennan; R A Skurray
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

2.  The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5.

Authors:  R Tierney; H Kirby; J Nagra; A Rickinson; A Bell
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  A new transcription factor for mitosis: in Schizosaccharomyces pombe, the RFX transcription factor Sak1 works with forkhead factors to regulate mitotic expression.

Authors:  Angad Garg; Bruce Futcher; Janet Leatherwood
Journal:  Nucleic Acids Res       Date:  2015-04-23       Impact factor: 16.971

4.  RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction.

Authors:  Laura Julien; Julie Chassagne; Cécile Peccate; Stéphanie Lorain; France Piétri-Rouxel; Olivier Danos; Sofia Benkhelifa-Ziyyat
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

5.  DNA-mediated association of two histone-bound complexes of yeast Chromatin Assembly Factor-1 (CAF-1) drives tetrasome assembly in the wake of DNA replication.

Authors:  Francesca Mattiroli; Yajie Gu; Tejas Yadav; Jeremy L Balsbaugh; Michael R Harris; Eileen S Findlay; Yang Liu; Catherine A Radebaugh; Laurie A Stargell; Natalie G Ahn; Iestyn Whitehouse; Karolin Luger
Journal:  Elife       Date:  2017-03-18       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.